
Writer
Kirti Kumbhar
M. Pharm QA
Kirti Kumbhar is an M.Pharm graduate with experience in Quality Assurance at Lupin Limited and a strong interest in clinical research, regulatory affairs, and Trial Master File (TMF) management. She has developed knowledge of regulatory documentation, quality systems, compliance, and healthcare research through her professional experience. Passionate about clinical development and continuous learning, Kirti is committed to supporting high-quality healthcare documentation, regulatory excellence, and research-driven healthcare advancements.
109
Articles written or reviewed
About Kirti
Kirti Kumbhar (M. Pharm QA) is a writer at Pharmacally, with 109 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Kirti Kumbhar
Health TidingsMerck’s Sac-TMT Cuts Death Risk by 32% in Endometrial Cancer
Clinical TrialsParabilis Reports 100% Disease Control With Zolucatetide in Desmoid Tumors
Clinical TrialsAbbVie Reports Phase 3 Success for Lutikizumab in Hidradenitis Suppurativa
Clinical TrialsSavara Reports Gas-Transfer Gains with Molgramostim in aPAP
Clinical TrialsRapport’s RAP-219 Delivers Significant YMRS Improvement in Phase 2
Health TidingsGilead Reports Positive Results for Emvistegrast in Ulcerative Colitis
Clinical TrialsZentalis Reports 15.8-Month Median Survival With Azenosertib in Cyclin E1-Positive Ovarian Cancer
New Drug ApprovalRoche Wins FDA Approval for Enspryng Despite Mixed Phase III Results
Clinical TrialsVanda VQW-765 Phase 3 Trial Fails in Social AnxietyOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala